NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in cell culture ...

Dr. Menon designed and conducted the humanized animal model studies for testing drugs against Measles virus infection. As such, he has hands-on experience with the effects of the drug NV-387. The data ...

Q3 2025 Earnings Call Transcript November 3, 2025 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $2.66, ...

In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial ...

KB801 for the treatment of neurotrophic keratitis (NK) The Company continues to enroll in EMERALD-1, the Company’s 2:1 randomized ... non-replicating herpes simplex virus type 1 viral vector used in ...

Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...

Assembly Biosciences Inc (($ASMB)) announced an update on their ongoing clinical study. Study Overview: Assembly Biosciences Inc. is conducting a ...

SOUTH SAN FRANCISCO, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, ...

The herpes simplex virus (HSV) antibodies test is a type of herpes simplex test that determines whether or not you’ve ever been exposed to this virus. Specifically, it’s a blood test that looks for ...

– Late-breaking oral presentation highlights interim Phase 1b data reported earlier this year for two cohorts in participants with recurrent genital herpes – – Statistically significant reductions in ...